Cookie policy: This site uses cookies (small files stored on your computer) to simplify and improve your experience of this website. Cookies are small text files stored on the device you are using to access this website. For more information please take a look at our terms and conditions. Some parts of the site may not work properly if you choose not to accept cookies.


Subscribe or Register

Existing user? Login


Ibuprofen raises blood pressure more than celecoxib

Study investigated the link between non-steroidal anti-inflammatory drugs and raised blood pressure and heart problems in patients who either had, or were at increased risk, of coronary artery disease. 

Non-steroidal anti-inflammatory drugs (NSAIDs) are one of the most widely used classes of drugs but they are associated with adverse cardiovascular safety, including raised blood pressure.

Researchers randomly assigned 444 patients with osteoarthritis or rheumatoid arthritis who either had, or were at increased risk, of coronary artery disease to daily celecoxib, ibuprofen or naproxen.

After four months, they found that the mean change from baseline in 24-hour ambulatory systolic blood pressure was not significant for celecoxib (-0.3 mmHg) or naproxen (+1.6 mmHg), but increased significantly in the ibuprofen group (+3.7 mmHg) compared with both baseline and celecoxib.

Significantly more ibuprofen- (23.2%) and naproxen-treated patients (19.0%) became hypertensive during treatment compared with the celecoxib group (10.3%).

Reporting in the European Heart Journal (online, 28 August 2017), the researchers said that prescribers should weigh up the benefits of NSAIDs against their risks, particularly in the case of ibuprofen[1].

Citation: Clinical Pharmacist DOI: 10.1211/CP.2017.20203680

Have your say

For commenting, please login or register as a user and agree to our Community Guidelines. You will be re-directed back to this page where you will have the ability to comment.

Recommended from Pharmaceutical Press

  • Drugs and the Liver

    Drugs and the Liver

    Drugs and the Liver assists practitioners in making pragmatic choices for their patients. It enables you to assess liver function and covers the principles of drug use in liver disease.

    £37.00Buy now
  • Introduction to Renal Therapeutics

    Introduction to Renal Therapeutics

    Introduction to Renal Therapeutics covers all aspects of drug use in renal failure. Shows the role of the pharmacist in patient care for chronic kidney disease.

    £37.00Buy now
  • Drugs in Use

    Drugs in Use

    Optimise drug therapy for your patients. These case studies help you bridge the gap between theoretical medicines knowledge and practical applications.

    £42.00Buy now
  • Disease Management

    Disease Management

    Disease Management covers the diseases commonly encountered in primary care by system, with common therapeutic issues. Includes case studies and self-assessment sections.

    £52.00Buy now
  • Workplace Drug Testing

    Workplace Drug Testing

    Explains drug testing regulatory frameworks and all aspects of drug analysis. Case studies of successful programmes are included.

    £79.00Buy now
  • Integrated Pharmacy Case Studies

    Integrated Pharmacy Case Studies

    Over 90 case studies based on real life patient-care scenarios. Each case includes learning outcomes and references.

    £42.00Buy now

Search an extensive range of the world’s most trusted resources

Powered by MedicinesComplete
  • Print
  • Share
  • Comment
  • Save
  • Print Friendly Version of this pagePrint Get a PDF version of this webpagePDF

Supplementary images

  • Ibuprofen and paracetamol packets

Newsletter Sign-up

Want to keep up with the latest news, comment and CPD articles in pharmacy and science? Subscribe to our free alerts.